CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. (Q53057906)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. |
scientific article |
Statements
CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. (English)
Takayuki Asahara
Toru Nakamura
Takuji Torimura
Hideki Iwamoto
Jyunichi Kurogi
Hiroto Inoue
Yukie Hori
Shuji Sumie
Nobuyoshi Fukushima
Masahiro Sakata
Hironori Koga
Mitsuhiko Abe
Yu Ikezono
Osamu Hashimoto
Takato Ueno
Kazuhiko Oho
Takashi Okamura
Seiya Okuda
Masaaki Ii
Michio Sata
1 October 2014
29
10
1830-1838
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
Sitelinks
Wikipedia(0 entries)
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(0 entries)
